Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1681/ASN.2016111206 http://scihub22266oqcxt.onion/10.1681/ASN.2016111206 C5491296!5491296!28465379     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Am+Soc+Nephrol 2017 ; 28 (7): 1960-72 Nephropedia Template TP {{tp|p=28465379|t=2017. Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells |pdf=|usr=}}{{28465379}} gab.com Text Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells JO: J Am Soc Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=28465379 #FOAvip Renal transplantation is the renal replacement modality of choice for suitable candidates with advanced CKD or ESRD. Prevention of rejection, however, requires treatment with nonspecific pharmacologic immunosuppressants that carry both systemic and nephrologic toxicities. Use of a patient?s own suppressive regulatory T cells (Tregs) is an attractive biologic approach to reduce this burden. Here, we review the immunologic underpinnings of Treg therapy and technical challenges to developing successful cell therapy. These issues include the selection of appropriate Treg subsets, ex vivo Treg expansion approaches, how many Tregs to administer and when, and how to care for patients after Treg administration. Twit Text FOAVip Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells ????J Am Soc Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=28465379 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28465379 #FOAvip English Wikipedia <ref>{{Cite pmid|28465379}}</ref> Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells #MMPMID28465379 Zwang NA; Leventhal JR J Am Soc Nephrol 2017[Jul]; 28 (7): 1960-72 PMID28465379show ga Renal transplantation is the renal replacement modality of choice for suitable candidates with advanced CKD or ESRD. Prevention of rejection, however, requires treatment with nonspecific pharmacologic immunosuppressants that carry both systemic and nephrologic toxicities. Use of a patient?s own suppressive regulatory T cells (Tregs) is an attractive biologic approach to reduce this burden. Here, we review the immunologic underpinnings of Treg therapy and technical challenges to developing successful cell therapy. These issues include the selection of appropriate Treg subsets, ex vivo Treg expansion approaches, how many Tregs to administer and when, and how to care for patients after Treg administration. äCell Therapy in Kidney Transplantation: Focus on Regulatory T Cells (epmc).pdf DeepDyve Pubget Overpricing